Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help…
New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Argus Research:
Jasper Hellweg, Analyst von Argus Research, stuft die ADR-Aktie von TEVA Pharmaceutical…
The Global Herpes Treatment Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Herpes Treatment Market…
The Global Allergy Therapeutics Market Size was Valued at USD 23.1 Billion in 2023 and the Worldwide Allergy Therapeutics Market…
The Global Contraceptive Drugs Market Size was Valued at USD 18.53 Billion in 2023 and the Worldwide Contraceptive Drugs Market…
The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…
The Global Anal Fissure Treatment Market Size was Valued at USD 1161.3 Million in 2023 and the Worldwide Anal Fissure…
The Global Lenalidomide Drug Market Size was Valued at USD 12.34 Billion in 2023 and the Worldwide Lenalidomide Drug Market…
The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…
The Global Prostate Health Market Size was Valued at USD 32.6 Billion in 2023 and the Worldwide Prostate Health Market…
London (www.aktiencheck.de) - Rating-Update:
Balaji Prasad, Analyst von Barclays, bestätigt die Empfehlung für die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN:…
Charlotte (www.aktiencheck.de) - Rating-Update:
BofA Securities stuft die Aktie von TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098, WKN: 883035, Ticker-Symbol: TEV, NYSE-Symbol:…
REYKJAVIK, ICELAND & PARSIPPANY, NJ — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)…
REYKJAVIK, Iceland and PARSIPPANY, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva…
Minneapolis (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von Piper Sandler:
Piper Sandler erhöht in einer aktuellen Aktienanalyse das Kursziel für die Aktie von…
TEVA earnings call for the period ending March 31, 2024.…
REYKJAVIK, Iceland and PARSIPPANY, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a…
REYKJAVIK, ICELAND & PARSIPPANY, NJ — Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE…
The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
…
BERLIN (dpa-AFX) - Deutsche Mittelständler reagieren mit Vorsicht auf den Krieg in Israel. "Einige Unternehmen fahren…
FRANKFURT/DÜSSELDORF (dpa-AFX) - Ob Fiebersäfte für Kinder, Hustenmittel, Blutdrucksenker, Brustkrebsmedikamente oder Magensäureblocker: Wer in der Apotheke…
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat Teva von "Neutral" auf "Underweight" abgestuft…
ZÜRICH (dpa-AFX) - Die Schweizer Großbank UBS hat Teva von "Neutral" auf "Sell" abgestuft und…
BERLIN/ULM (dpa-AFX) - Der Geschäftsführer des Ulmer Arzneiherstellers Ratiopharm, Andreas Burkhardt, hat Lieferengpässe bei Medikamenten in…